MedTrace Logo

Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain

NCT07559682 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-04-30

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of selective COX-2 inhibitors{ etoricoxib vs celecoxib )in relieving orthodontic pain , after initial bonding and arch wire insertion.

Conditions

  • Orthodontic Pain (D013850)

Interventions

DRUG

Celecoxib

Group A will be given Celecoxib 50mg once a day.

DRUG

Etoricoxib (Treatment Group)

Group B will be given Etoricoxib 60mg once a day.

Sponsors & Collaborators

  • Sharif Medical Research Center

    lead OTHER

Principal Investigators

  • Faiza Malik, BDS, FCPS · Essentia Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-08
Primary Completion
2025-08-18
Completion
2026-04-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07559682 on ClinicalTrials.gov